NM_012301.4:c.4259G>A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_012301.4(MAGI2):​c.4259G>A​(p.Gly1420Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000751 in 931,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 0.0000075 ( 0 hom. )

Consequence

MAGI2
NM_012301.4 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.04

Publications

0 publications found
Variant links:
Genes affected
MAGI2 (HGNC:18957): (membrane associated guanylate kinase, WW and PDZ domain containing 2) The protein encoded by this gene interacts with atrophin-1. Atrophin-1 contains a polyglutamine repeat, expansion of which is responsible for dentatorubral and pallidoluysian atrophy. This encoded protein is characterized by two WW domains, a guanylate kinase-like domain, and multiple PDZ domains. It has structural similarity to the membrane-associated guanylate kinase homologue (MAGUK) family. [provided by RefSeq, Jul 2008]
MAGI2 Gene-Disease associations (from GenCC):
  • nephrotic syndrome 15
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1822891).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAGI2NM_012301.4 linkc.4259G>A p.Gly1420Glu missense_variant Exon 22 of 22 ENST00000354212.9 NP_036433.2 Q86UL8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAGI2ENST00000354212.9 linkc.4259G>A p.Gly1420Glu missense_variant Exon 22 of 22 1 NM_012301.4 ENSP00000346151.4 Q86UL8-1

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
AF:
0.00000751
AC:
7
AN:
931486
Hom.:
0
Cov.:
30
AF XY:
0.00000229
AC XY:
1
AN XY:
436496
show subpopulations
African (AFR)
AF:
0.000109
AC:
2
AN:
18318
American (AMR)
AF:
0.00
AC:
0
AN:
3704
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8414
East Asian (EAS)
AF:
0.00
AC:
0
AN:
13444
South Asian (SAS)
AF:
0.00
AC:
0
AN:
18024
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8918
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2106
European-Non Finnish (NFE)
AF:
0.00000606
AC:
5
AN:
825106
Other (OTH)
AF:
0.00
AC:
0
AN:
33452
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.589
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
30
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 02, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.4259G>A (p.G1420E) alteration is located in exon 22 (coding exon 22) of the MAGI2 gene. This alteration results from a G to A substitution at nucleotide position 4259, causing the glycine (G) at amino acid position 1420 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.061
T;T;.;.
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.33
FATHMM_MKL
Benign
0.084
N
LIST_S2
Benign
0.63
T;T;T;T
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.18
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
.;N;.;.
PhyloP100
1.0
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
0.55
.;N;N;.
REVEL
Benign
0.082
Sift
Uncertain
0.018
.;D;D;.
Sift4G
Benign
0.39
T;T;T;T
Polyphen
0.99, 1.0
.;D;D;.
Vest4
0.20, 0.34
MutPred
0.24
.;Gain of solvent accessibility (P = 0.024);.;.;
MVP
0.082
MPC
1.4
ClinPred
0.54
D
GERP RS
1.9
Varity_R
0.085
gMVP
0.096
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1405463982; hg19: chr7-77648741; API